HUANG Michael Fangching;STAMLER David;AUSPEX PHARMACEUTICALS INC.
发明人:
STAMLER David,HUANG Michael Fangching
申请号:
IL25412117
公开号:
IL254121D0
申请日:
2017.08.23
申请国别(地区):
IL
年份:
2017
代理人:
摘要:
Disclosed herein are new dosage regimens for deuterium-substituted benzoquinoline compounds, and methods for the treatment of abnormal muscular activity, movement disorders, and related conditions.